“…In patients with cancer, high levels of circulating ICAM-1 have been found to be associated with the presence of liver metastases in gastric, colonic, gall bladder and pancreatic cancer (Tsujisaki et al, 1991), with poor survival of patients with malignant melanoma (Harning et al, 1991;Altomonte et al, 1992;Kageshita et al, 1992Kageshita et al, , 1993Viac et al, 1993) and correlated with disease stage and progression in Hodgkin's disease (Gruss et al, 1993). Soluble forms of E-cadherin have been identified in serum and urine of normal individuals and patients with cancer and cutaneous diseases (Katayama et al, 1994b;Banks et al, 1995;Matsuyoshi et al, 1995).…”